Early measurable residual disease detection post-haematopoietic stem cell transplantation in acute myeloid leukaemia

Background: Detection of measurable residual disease (MRD) is becoming the standard of care in the prognostication of acute myeloid leukaemia post-chemotherapy, but its role in early post-haematopoietic stem cell transplantation (HSCT) is less defined. Objectives: This study aims to examine the role...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sze P. Tsui, Stephen S. Y. Lam, Chun H. Au, Chi Y. Fung, Beca B. K. Ip, Anthony T. C. Wong, Henry C. M. Leung, Wing H. Lai, Ho W. Ip, Edmond S. K. Ma, Garret M. K. Leung, Joycelyn P. Y. Sim, Anskar Y. H. Leung
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publishing 2025-11-01
Col·lecció:Therapeutic Advances in Hematology
Accés en línia:https://doi.org/10.1177/20406207251389815
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars